Embecta (EMBC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.27, -2.79% vs the prior close of $6.45.
- Volume 622.67K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EMBC dips 2.8% to $6.27. Closed at $6.27, -2.79% vs the prior close of $6.45. Day range $6.26–$6.52, opened at $6.51.
EMBC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EMBC dips 2.8% to $6.27
- Closed at $6.27, -2.79% vs the prior close of $6.45. Day range $6.26–$6.52, opened at $6.51.
- Volume was 622.67K shares, 0.4x its 50-day average of 1.38M — lighter than usual.
- Price is +15.4% vs its 50-day average ($5.43) and -6.8% vs its 200-day average ($6.73).
- 52-week range $2.77–$14.91; today's close sits at 29% of that range, 57.9% below the 52-week high.
Oct 15, 2026 — EMBC jumps 4.4% to $6.45, a 3-month high
- Closed at $6.45, +4.37% vs the prior close of $6.18. Day range $6.19–$6.58, opened at $6.19.
- Volume was 983.70K shares, 0.7x its 50-day average of 1.39M.
- Price is +19.9% vs its 50-day average ($5.38) and -4.5% vs its 200-day average ($6.76).
- 52-week range $2.77–$14.91; today's close sits at 30% of that range, 56.7% below the 52-week high.
Oct 14, 2026 — EMBC dips 0.3% to $6.18
- Closed at $6.18, -0.32% vs the prior close of $6.20. Day range $6.11–$6.25, opened at $6.19.
- Volume was 651.50K shares, 0.5x its 50-day average of 1.39M — lighter than usual.
- Price is +16.2% vs its 50-day average ($5.32) and -8.9% vs its 200-day average ($6.78).
- 52-week range $2.77–$14.91; today's close sits at 28% of that range, 58.6% below the 52-week high.
Oct 13, 2026 — EMBC jumps 3.5% to $6.20, a 3-month high
- Closed at $6.20, +3.51% vs the prior close of $5.99. Day range $5.93–$6.24, opened at $6.01.
- Volume was 732.90K shares, 0.5x its 50-day average of 1.40M — lighter than usual.
- Price is +17.6% vs its 50-day average ($5.27) and -9.0% vs its 200-day average ($6.81).
- 52-week range $2.77–$14.91; today's close sits at 28% of that range, 58.4% below the 52-week high.
Oct 12, 2026 — EMBC jumps 5.4% to $5.99, a 3-month high
- Closed at $5.99, +5.36% vs the prior close of $5.68. Day range $5.77–$6.11, opened at $5.77.
- Volume was 1.05M shares, 0.7x its 50-day average of 1.41M.
- Price is +14.7% vs its 50-day average ($5.22) and -12.5% vs its 200-day average ($6.84).
- 52-week range $2.77–$14.91; today's close sits at 27% of that range, 59.8% below the 52-week high.
Oct 9, 2026 — EMBC dips 1.1% to $5.68, 3 down days in a row
- Closed at $5.68, -1.13% vs the prior close of $5.75. Day range $5.67–$5.95, opened at $5.74.
- Volume was 583.10K shares, 0.4x its 50-day average of 1.42M — lighter than usual.
- Price is +9.8% vs its 50-day average ($5.18) and -17.3% vs its 200-day average ($6.87).
- 52-week range $2.77–$14.91; today's close sits at 24% of that range, 61.9% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — EMBC dips 2.7% to $5.75
- Closed at $5.75, -2.71% vs the prior close of $5.91. Day range $5.72–$5.97, opened at $5.89.
- Volume was 1.14M shares, 0.8x its 50-day average of 1.42M.
- Price is +12.0% vs its 50-day average ($5.14) and -16.7% vs its 200-day average ($6.90).
- 52-week range $2.77–$14.91; today's close sits at 25% of that range, 61.4% below the 52-week high.
Oct 7, 2026 — EMBC dips 0.7% to $5.91
- Closed at $5.91, -0.67% vs the prior close of $5.95. Day range $5.86–$6.16, opened at $5.86.
- Volume was 994.10K shares, 0.7x its 50-day average of 1.42M.
- Price is +16.0% vs its 50-day average ($5.09) and -14.8% vs its 200-day average ($6.93).
- 52-week range $2.77–$14.91; today's close sits at 26% of that range, 60.4% below the 52-week high.
Oct 6, 2026 — EMBC rises 1.2% to $5.95, a 3-month high
- Closed at $5.95, +1.19% vs the prior close of $5.88. Day range $5.80–$6.14, opened at $5.90.
- Volume was 1.21M shares, 0.9x its 50-day average of 1.41M.
- Price is +17.9% vs its 50-day average ($5.05) and -14.5% vs its 200-day average ($6.96).
- 52-week range $2.77–$14.91; today's close sits at 26% of that range, 60.1% below the 52-week high.
Oct 5, 2026 — EMBC jumps 4.1% to $5.88
- Closed at $5.88, +4.07% vs the prior close of $5.65. Day range $5.57–$5.97, opened at $5.59.
- Volume was 1.04M shares, 0.7x its 50-day average of 1.40M.
- Price is +17.7% vs its 50-day average ($5.00) and -15.9% vs its 200-day average ($6.99).
- 52-week range $2.77–$14.91; today's close sits at 26% of that range, 60.6% below the 52-week high.
Oct 2, 2026 — EMBC dips 2.4% to $5.65
- Closed at $5.65, -2.42% vs the prior close of $5.79. Day range $5.49–$5.82, opened at $5.79.
- Volume was 1.14M shares, 0.8x its 50-day average of 1.41M.
- Price is +14.2% vs its 50-day average ($4.95) and -19.5% vs its 200-day average ($7.02).
- 52-week range $2.77–$14.91; today's close sits at 24% of that range, 62.1% below the 52-week high.
EMBC latest news & SEC filings
Every SEC filing by or about EMBC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Morris Milton Mayo sold 6,293 shares at $5.88 (≈$37.00K) on Sep 4, 2026
- Morris Milton Mayo sold 6,293 shares at $5.88 (≈$37.00K) on Sep 4, 2026
- Morris Milton Mayo sold 6,293 shares at $5.88 (≈$37.00K) on Sep 4, 2026
- Morris Milton Mayo sold 6,293 shares at $5.88 (≈$37.00K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kurdikar Devdatt bought 30,000 shares at $4.70 (≈$141.00K) on Aug 12, 2026
- Kurdikar Devdatt bought 30,000 shares at $4.70 (≈$141.00K) on Aug 12, 2026
- Kurdikar Devdatt bought 30,000 shares at $4.70 (≈$141.00K) on Aug 12, 2026
- Kurdikar Devdatt bought 30,000 shares at $4.70 (≈$141.00K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Elguicze Jacob bought 20,000 shares at $4.67 (≈$93.40K) on Aug 12, 2026
- Elguicze Jacob bought 20,000 shares at $4.67 (≈$93.40K) on Aug 12, 2026
- Elguicze Jacob bought 20,000 shares at $4.67 (≈$93.40K) on Aug 12, 2026
- Elguicze Jacob bought 20,000 shares at $4.67 (≈$93.40K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mann Jeffrey Z bought 20,000 shares at $4.99 (≈$99.80K) on Aug 12, 2026
- Mann Jeffrey Z bought 20,000 shares at $4.99 (≈$99.80K) on Aug 12, 2026
- Mann Jeffrey Z bought 20,000 shares at $4.99 (≈$99.80K) on Aug 12, 2026
- Mann Jeffrey Z bought 20,000 shares at $4.99 (≈$99.80K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hombach Robert J. bought 45,000 shares at $4.97 (≈$223.65K) on Aug 12, 2026
- Hombach Robert J. bought 45,000 shares at $4.97 (≈$223.65K) on Aug 12, 2026
- Hombach Robert J. bought 45,000 shares at $4.97 (≈$223.65K) on Aug 12, 2026
- Hombach Robert J. bought 45,000 shares at $4.97 (≈$223.65K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $271.70M (prior year $295.50M) (-8.1% vs Jun 30, 2025)
- Net income: $21.10M (prior year $45.50M) (-53.6% vs Jun 30, 2025)
- Diluted EPS: $0.36 (prior year $0.78) (-53.8% vs Jun 30, 2025)
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Jul 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade EMBC
- Last results release: Aug 7, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 5, 2026, Nov 25, 2025. Based on that rhythm, the next report is likely around Nov 6, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.37% (largest 5.5%).
- Liquidity: about 915.56K shares (≈$5.74M) trade per day on average.
- 52-week position: $6.27 vs a range of $2.77–$14.91 (29% of the range).
- Dividends: last ex-dividend date Aug 27, 2026 ($0.01/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 4 sales; latest: Milton Mayo Morris sold 6,293 shares on Sep 4, 2026.
- Latest filings: 10-Q Aug 7, 2026; 8-K Aug 7, 2026; 8-K May 15, 2026.
- Share count: 56.66M shares outstanding (Jul 31, 2026), -3.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
EMBC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.51 | 6.52 | 6.26 | 6.27 | 622.67K |
| Oct 15, 2026 | 6.19 | 6.58 | 6.19 | 6.45 | 983.70K |
| Oct 14, 2026 | 6.19 | 6.25 | 6.11 | 6.18 | 651.50K |
| Oct 13, 2026 | 6.01 | 6.24 | 5.93 | 6.20 | 732.90K |
| Oct 12, 2026 | 5.77 | 6.11 | 5.77 | 5.99 | 1.05M |
| Oct 9, 2026 | 5.74 | 5.95 | 5.67 | 5.68 | 583.10K |
| Oct 8, 2026 | 5.89 | 5.97 | 5.72 | 5.75 | 1.14M |
| Oct 7, 2026 | 5.86 | 6.16 | 5.86 | 5.91 | 994.10K |
| Oct 6, 2026 | 5.90 | 6.14 | 5.80 | 5.95 | 1.21M |
| Oct 5, 2026 | 5.59 | 5.97 | 5.57 | 5.88 | 1.04M |
| Oct 2, 2026 | 5.79 | 5.82 | 5.49 | 5.65 | 1.14M |
| Oct 1, 2026 | 5.74 | 5.95 | 5.65 | 5.79 | 1.05M |
| Sep 30, 2026 | 5.81 | 5.90 | 5.63 | 5.66 | 1.42M |
| Sep 29, 2026 | 5.93 | 5.96 | 5.65 | 5.76 | 990.90K |
| Sep 28, 2026 | 5.83 | 5.98 | 5.76 | 5.93 | 680.90K |
| Sep 25, 2026 | 5.67 | 5.93 | 5.63 | 5.90 | 791.80K |
| Sep 24, 2026 | 5.63 | 5.72 | 5.45 | 5.62 | 925.90K |
| Sep 23, 2026 | 5.59 | 5.66 | 5.54 | 5.58 | 692.10K |
| Sep 22, 2026 | 5.38 | 5.61 | 5.38 | 5.59 | 681.20K |
| Sep 21, 2026 | 5.24 | 5.34 | 5.13 | 5.30 | 930.30K |
About Embecta
Embecta (EMBC) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in PARSIPPANY, NJ. State of incorporation: DE. Fiscal year ends September 30. SEC CIK 1872789.
EMBC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carrie L Anderson | Director | Feb 13, 2026 |
| Robert J. Hombach | Director | Aug 13, 2026 |
| Devdatt Kurdikar | President and CEO | Aug 13, 2026 |
| Milton Mayo Morris | Director | Sep 8, 2026 |
| Claire Pomeroy | Director | Feb 13, 2026 |
| Karen Prange | Director | Feb 13, 2026 |
| Christopher R Reidy | Director | Feb 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jean Casner | Chief Human Resources Officer | Aug 11, 2026 |
| Shaun Curtis | SVP, Global Manuf./Sup. Chain | Dec 1, 2025 |
| Jacob Elguicze | SVP and CFO | Aug 13, 2026 |
| Devdatt Kurdikar | President and CEO | Aug 13, 2026 |
| Jeffrey Z Mann | Pres, Pharm Svc&Prod Mgmt, CLO | Aug 13, 2026 |
| Anthony M. Roth | VP, Chief Accounting Officer | Jun 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 4, 2026 | Milton Mayo Morris | Sale | 6,293 | $5.88 |
| Sep 4, 2026 | Milton Mayo Morris | Sale | 6,293 | $5.88 |
| Sep 4, 2026 | Milton Mayo Morris | Sale | 6,293 | $5.88 |
| Sep 4, 2026 | Milton Mayo Morris | Sale | 6,293 | $5.88 |
| Aug 12, 2026 | Devdatt Kurdikar | Buy | 30,000 | $4.70 |
| Aug 12, 2026 | Devdatt Kurdikar | Buy | 30,000 | $4.70 |
| Aug 12, 2026 | Devdatt Kurdikar | Buy | 30,000 | $4.70 |
| Aug 12, 2026 | Devdatt Kurdikar | Buy | 30,000 | $4.70 |
| Aug 12, 2026 | Jeffrey Z Mann | Buy | 20,000 | $4.99 |
| Aug 12, 2026 | Jeffrey Z Mann | Buy | 20,000 | $4.99 |
| Aug 12, 2026 | Jeffrey Z Mann | Buy | 20,000 | $4.99 |
| Aug 12, 2026 | Jeffrey Z Mann | Buy | 20,000 | $4.99 |
| Aug 12, 2026 | Jacob Elguicze | Buy | 20,000 | $4.67 |
| Aug 12, 2026 | Jacob Elguicze | Buy | 20,000 | $4.67 |
| Aug 12, 2026 | Jacob Elguicze | Buy | 20,000 | $4.67 |
EMBC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | $1.08B | $95.40M | 1.62 | $191.70M |
| Sep 30, 2024 | $1.12B | $78.30M | 1.34 | $35.70M |
| Sep 30, 2023 | $1.12B | $70.40M | 1.22 | $67.70M |
| Sep 30, 2022 | $1.13B | $223.60M | 3.89 | $412.20M |
| Sep 30, 2021 | $1.17B | $414.80M | 7.28 | $456.30M |
Latest balance sheet: total assets $1.27B, total liabilities $—, cash $214.70M (as of Jun 30, 2026).
EMBC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 7, 2026 | 8-K Item 2.02 (results) | $4.42 |
| May 5, 2026 | 8-K Item 2.02 (results) | $3.90 |
| Feb 5, 2026 | 8-K Item 2.02 (results) | $10.47 |
| Nov 25, 2025 | 8-K Item 2.02 (results) | $13.58 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $12.28 |
| May 9, 2025 | 8-K Item 2.02 (results) | $11.97 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $17.73 |
| Nov 26, 2024 | 8-K Item 2.02 (results) | $18.70 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 9, 2024 | 8-K Item 2.02 (results) | — |
| Nov 21, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EMBC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.